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OBJECTIVES We wished to assess the profile and outcomes of patients with ventricular septal rupture (VSR) in
the setting of cardiogenic shock (CS) complicating acute myocardial infarction (MI).
BACKGROUND Cardiogenic shock is often seen with VSR complicating acute MI. Despite surgical therapy,
mortality in such patients is high.
METHODS We analyzed 939 patients enrolled in the SHOCK Trial Registry of CS in acute infarction,
comparing 55 patients whose shock was associated with VSR with 884 patients who had
predominant left ventricular failure.
RESULTS Rupture occurred a median 16 h after infarction. Patients with VSR tended to be older (p 5
0.053), were more often female (p 5 0.002) and less often had previous infarction (p ,
0.001), diabetes mellitus (p 5 0.015) or smoking history (p 5 0.033). They also underwent
right-heart catheterization, intra-aortic balloon pumping and bypass surgery significantly
more often. Although patients with rupture had less severe coronary disease, their in-hospital
mortality was higher (87% vs. 61%, p , 0.001). Surgical repair was performed in 31 patients
with rupture (21 had concomitant bypass surgery); 6 (19%) survived. Of the 24 patients
managed medically, only 1 survived.
CONCLUSIONS There is a high in-hospital mortality rate when CS develops as a result of VSR. Ventricular
septal rupture may occur early after infarction, and women and the elderly may be more
susceptible. Although the prognosis is poor, surgery remains the best therapeutic option in
this setting. (J Am Coll Cardiol 2000;36:1110–6) © 2000 by the American College of
Cardiology
Ventricular septal rupture (VSR) is an uncommon but
well-recognized mechanical complication of acute myocar-
dial infarction (MI). Seen with anterior or inferior MI, it
carries a poor prognosis. Advances in echocardiography,
including Doppler and multiplane transesophageal imaging,
now enable the reliable diagnosis, localization and quanti-
fication of intracardiac shunting in patients with VSR (1–3).
Intra-aortic balloon pumping (IABP) provides temporary
but effective early medical stabilization. The first successful
surgical repair by Cooley et al. (4) established the role of
surgical intervention, although surgery was restricted ini-
tially to long-term survivors (5–7). The recognized limita-
tions of medical management (8,9), the availability of the
IABP (10) and improvements in surgical technique and
myocardial protection soon led to aggressive surgical man-
agement for most patients with VSR (11,12). Despite the
increasing use of surgery and the reasonable long-term
prognosis for most surgical survivors (13–15), most patients
with VSR and cardiogenic shock (CS) do not survive
(16–21). Precarious hemodynamic characteristics, the com-
plexity of the surgery, ongoing ischemia and underlying left
ventricular (LV) and right ventricular (RV) dysfunction are
major contributors to this poor outcome.
The SHould we emergently revascularize Occluded Cor-
onaries in cardiogenic shocK? (SHOCK) study was a
prospective, multicenter registry and randomized trial of CS
complicating acute MI. The randomized trial was restricted
to patients with predominant LV pump failure; thus, those
with a mechanical etiology of CS were excluded. Such
patients were followed prospectively as part of the SHOCK
Trial Registry, however. We wished to assess the effect of
surgical repair on outcomes of VSR and the profile and
outcomes of patients with CS complicating acute MI who
did and did not suffer VSR.
METHODS
The design and inclusion criteria for the randomized
SHOCK Trial have been previously published (22). Details
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of the nonrandomized SHOCK Trial Registry are pub-
lished in this supplementary issue of the Journal (23).
Study population. There were 1,190 patients overall in the
SHOCK Trial Registry. Of these, CS was due to predom-
inant LV failure in 884 patients and due to VSR in 55.
These 939 patients form the basis of this report. In all, 573
(61%) were registered in 24 U.S. centers; 196 (21%) in five
Canadian centers; 55 (6%) in four Belgian centers; and 115
(12%) in Australia, New Zealand or Brazil. The mode of
VSR diagnosis (echo/LV angiogram/right heart catheter-
ization) was not recorded in the individual case report
forms.
Definitions. Predominant LV failure was identified as the
etiology for CS shock in the absence of other major shock
categories such as isolated RV failure; acute, severe mitral
regurgitation (MR); VSR; tamponade/LV rupture; prior
severe valvular heart disease; or iatrogenic shock. Recurrent
ischemia was defined as rest angina or ischemic symptoms
$5 min with ST-segment depression, T-wave inversion, or
both, without cardiac enzyme elevation. The index MI was
defined as the infarction that caused CS. Re-infarction was
defined as 1) recurrent chest pain or ischemic symptoms
$30 min and recurrent ST-segment elevation, new Q
waves, or new left bundle branch block; 2) total creatine
kinase (CK) at least twice the upper limit of normal and
.25% or 200 U/mL over the previous value, with an
elevated CK-MB level; or 3) a rise in CK-MB above the
upper limit of normal after it had reverted to the normal
range.
Statistical analysis. Continuous variables were summa-
rized as mean 6 SD or median (interquartile range), and
categorical variables as percentages. We compared the
characteristics and outcomes of the 55 patients with VSR
with those of the 884 patients in the SHOCK Trial Registry
whose CS was caused by predominant LV failure. The
Fisher exact test was used to assess differences in dichoto-
mous or unordered categorical covariates. The Wilcoxon
rank-sum statistic was used to compare the distributions of
continuous variables between the two groups. For normally
distributed covariates, the Student t-test was used. Gender,
age and weight differed between the two groups. To
determine whether VSR was associated with mortality after
adjusting for these covariates, a logistic regression model
was fit. We also attempted to create univariable logistic
regression models to determine risk factors for any surgical
mortality associated with VSR, but the small sample size
coupled with the low survival rate resulted in computational
problems and unstable coefficients. Therefore, descriptive
statistics similar to those outlined above were used to profile
survival in this study group. A p value of ,0.05 was
considered statistically significant.
RESULTS
Patient characteristics. Table 1 displays the baseline char-
acteristics for the 55 patients with VSR and the 884 patients
with predominant LV failure. The VSR group tended to be
older (p 5 0.053) and had a higher proportion of women.
They weighed less than the group with LV failure, and they
were more likely to be transfer admissions. The VSR group
had a better risk profile with less history of MI, smoking and
diabetes mellitus. After adjusting for age and weight, female
gender was an independent predictor of VSR (odds ratio,
2.32; 95% confidence interval, 1.08 to 4.96; p 5 0.031).
Abbreviations and Acronyms
BP 5 blood pressure
CAD 5 coronary artery disease
CK 5 creatine kinase
CS 5 cardiogenic shock
ECG 5 electrocardiogram, electrocardiographic
IABP 5 intra-aortic balloon pump
LV 5 left ventricular, left ventricle
MI 5 myocardial infarction
MR 5 mitral regurgitation
RV 5 right ventricular, right ventricle
SHOCK 5 SHould we emergently revascularize
Occluded Coronaries in cardiogenic shocK?
TIMI 5 Thrombolysis In Myocardial Infarction
VSR 5 ventricular septal rupture
Table 1. Baseline Characteristics of Patients With CS and VSR or Predominant LV Failure
VSR
(n 5 55)
Predominant LV
Failure (n 5 884)
p
Value
Age (yrs) 72 6 10 69 6 12 0.053
Female gender 58% 36% 0.002
Weight (kg) 71.5 6 16.5 (35) 75.5 6 16.1 (531) 0.046
Height (cm) 166.6 6 10.4 (27) 168.4 6 10.2 (451) 0.172
Transferred from elsewhere 64% 42% 0.002
History of hypertension 50% 52% 0.887
Diabetes 17% 33% 0.015
Smoking 35% 52% 0.033
History of elevated lipids 23% (26) 40% (443) 0.099
History of peripheral vascular disease 16% (32) 19% (560) 0.817
History of myocardial infarction 17% 40% , 0.001
History of angioplasty 6% 7% 1.000
History of bypass surgery 2% 10% 0.052
Data presented are mean 6 SD, or percentages. () 5 subgroup n when data was not available for the entire group.
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Clinical profile of VSR patients. Most patients with VSR
in the SHOCK Trial Registry (71%) had two systolic blood
pressure (BP) measures ,90 mm Hg recorded 30 min apart.
In addition, 86% also required vasopressors to maintain
systolic BP. Features of tissue hypoperfusion, as manifested
by oliguria (,30 mL/h), were present in 81% of patients,
and 83% had cold, diaphoretic extremities. The index MI
was characterized by ST-segment elevation in 94% of the
subjects, and .80% had ST-segment elevation when the
diagnosis of shock was made. The median time from MI to
diagnosis of VSR (n 5 24) was 16 h (interquartile range,
1.8 h to 42.5 h). The median time from MI to VSR in 13
subjects given thrombolytic therapy was 18 h (5 h to 36 h).
This did not differ significantly from the median time of 6 h
(1 h to 89 h) among the 11 patients not given thrombolytics
(p 5 0.885).
Hemodynamic data (Table 2). The VSR patients more
often underwent right-heart catheterization. Consistent
with the presence of left-to-right shunting, patients with
VSR had higher recorded right atrial, RV diastolic and
pulmonary arterial systolic pressures. Left ventricular ejec-
tion fraction, measured on the same day or after shock, also
was greater for the VSR group. The ratio of pulmonary to
systemic blood flow was available for 10 patients with VSR;
it averaged 2.6 6 1.7.
Location of MI and angiographic findings. The electro-
cardiographic (ECG) location of MI was recorded in 52 of
the 55 patients with VSR. The index MI was inferior in 26
patients, anterior in 22, anterior and inferior in three and
apicolateral in one patient. Among those with inferior MI,
five had lateral involvement, four posterior and one postero-
lateral. Similarly, four patients with anterior MI had in-
volvement of the lateral wall, and another five had involve-
ment of the apicolateral leads. In 11 of 32 patients with
more detailed data (ECG, echocardiographic or hemody-
namic), there was evidence of accompanying RV MI. Severe
RV dysfunction was reported in four of these patients,
whereas two patients each had moderate and mild impair-
ment. Data were unavailable for three patients.
Coronary angiography was performed in 35 patients with
VSR. The majority had single- or double-vessel coronary
artery disease (CAD) (26% and 43%, respectively); a mi-
nority had left main (6%) or triple-vessel CAD (31%). The
infarct-related artery was identified in 26 patients; it was
most often the right (12/26, 46%) or left anterior descend-
ing coronary artery (11/26, 42%). The left circumflex artery
was the culprit vessel in only three cases. All culprit vessels
had .90% stenosis, and the overwhelming majority (22/26)
exhibited Thrombolysis In Myocardial Infarction (TIMI)
grade 0 or 1 flow. The median LV ejection fraction was 35%
(interquartile range, 25% to 40%) in the 13 subjects who
underwent ventriculography. Table 3 shows the angio-
graphic findings of the VSR patients and those with
Table 2. Hemodynamic Data for Patients With CS and VSR or Predominant LV Failure
VSR
(n 5 55)
LV Failure
(n 5 884)
p
Value
Right-heart catheterization 82% 64% 0.008
Heart rate (beats/min) 102 6 23 (50) 95 6 26 (832) 0.054
Systolic BP (mm Hg) 83 6 13 (50) 88 6 23 (833) 0.072
Diastolic BP (mm Hg) 52 6 10 (45) 53 6 17 (729) 0.304
Lowest systolic blood pressure (mm Hg) 71 6 19 (36) 68 6 17 (604) 0.065
Right atrial pressure (mm Hg) 18 6 7 (25) 14 6 7 (276) 0.009
Right ventricular systolic pressure (mm Hg) 56 6 21 (10) 46 6 20 (124) 0.091
Right ventricular diastolic pressure (mm Hg) 20 6 6 (10) 15 6 10 (118) 0.019
Pulmonary arterial systolic pressure (mm Hg) 48 6 17 (27) 41 6 13 (341) 0.050
Pulmonary arterial diastolic pressure (mm Hg) 23 6 7 (26) 24 6 8 (343) 0.295
Pulmonary capillary wedge pressure (mm Hg) 22 6 9 (42) 24 6 9 (534) 0.287
Left ventricular ejection fraction* (%) 40 6 11 (16) 30 6 13 (300) 0.002
Data presented as mean 6 SD (number of patients with data available), or percentages. *Left ventricular ejection fraction same
day as or after shock diagnosis. Hemodynamic measurements may have been obtained on support measures.
Beats/min 5 beats per minute.
Table 3. Angiographic Findings in Patients With CS and VSR
or Predominant LV Failure
Current Study
Prior
Study
VSR*VSR
LV
Failure
Infarct-related artery†† (n 5 26) (n 5 405)
Right coronary 46% 28%
Left anterior descending 42% 45%
Left circumflex 12% 15%
Severity of disease†
(n 5 35) (n 5 518) (n 5 232)
0 vessel 0% 1% 0%
1 vessel 26% 21% 44%
2 vessel 43% 21% 36%
3 vessel 31% 57% 19%
Left main 6% 17% NA
Ejection fraction (%) 35 (n 5 13) 30 (n 5 173)
*Distribution of atherosclerotic coronary artery disase in previously reported series also
shown for comparison (24). †Distribution differed significantly between the VSR and
LV failure groups (p 5 0.008). ††Culprit artery was similar for both groups (p 5
0.184). Data presented are medians or percentages.
NA 5 not available.
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predominant LV failure. Also included for comparison are
pooled angiographic findings for 232 patients with VSR
previously reported (24). The extent of CAD appeared to be
greatest in the group with predominant LV failure, but the
VSR patients in this report appeared to have more extensive
CAD than those previously reported.
Treatment (Table 4). Intravenous thrombolytic therapy
was given to 24 patients with VSR, beginning a median
2.9 h after MI onset (interquartile range, 1.9 h to 4.1 h).
Vasopressor therapy was given to 97% (36/37) of VSR
patients; 75% (41/55) were mechanically ventilated; and
intra-aortic balloon pump (IABP) was inserted in 75%
(41/55). Within 30 min of initiation of IABP support, the
median systolic BP in the VSR group had increased from
81 mm Hg (interquartile range, 70 mm Hg to 92 mm Hg)
to 102 mm Hg (87 mm Hg to 120 mm Hg) (p , 0.001).
Angioplasty of the infarct-related artery was performed in
five VSR patients, with an 80% procedural success rate
(residual stenosis ,50%). Three of the VSR patients un-
dergoing angioplasty died without attempted VSR repair.
Another went for surgical repair and later died, and one
angioplasty patient survived to discharge. Thirty-one of the
55 VSR patients underwent surgical repair of the VSR (see
following text). The time from MI to initiation of throm-
bolytic therapy was similar between VSR patients and those
with predominant LV dysfunction. The VSR group was
more likely to receive IABP support. Bypass surgery also
was performed more often in the VSR patients, whereas
angioplasty was used less often.
Outcomes. The overall in-hospital survival rate was only
13% (7/55) for patients with VSR, significantly lower than
the 39% rate for patients with predominant LV failure (p ,
0.001). Recurrent ischemia occurred more often in the VSR
group (33% vs. 19%; p 5 0.05). The rates of recurrent MI
before shock onset did not differ (14% for the VSR group vs.
8%; p 5 0.226). The median highest total CK was
1,188 U/L in the VSR patients and 1,923 U/L in the
patients with LV failure patients (p 5 0.055).
Surgery. Ventricular septal rupture repair was performed in
31 of the 55 patients, 21 of whom had concomitant
coronary artery bypass grafting. Three patients had accom-
panying LV free-wall rupture; another had RV free-wall
rupture; and three others underwent aneurysmectomy. The
median perfusion time was 201 min (interquartile range,
158 min to 262 min; n 5 16), and the median cross-clamp
time was 130 min (interquartile range, 90 min to 164 min;
n 5 16). Of those undergoing bypass surgery, 90% had
complete revascularization, though saphenous vein grafts
were used exclusively. Overall mortality in the surgical
group was 81% (25/31) and was uniform across centers
enrolling in the SHOCK Trial Registry. Of the 24 patients
not undergoing surgical VSR repair, only one survived.
Patients undergoing surgical repair were younger (median
72 years vs. 77 years; p 5 0.04) than their medically treated
counterparts. We were unable to construct mortality models
to predict the survival of VSR patients undergoing surgical
repair, because of the small sample size (31 patients with
only six survivors).
Profile of survivors. Six of the overall seven survivors had
VSR repair. Survivors of VSR repair (n 5 6) are compared
with surgical nonsurvivors in Table 5. Surgical survivors
appear to have more anterior/apical MI and to have longer
times from MI onset to shock onset, from MI onset to VSR
onset, and from shock onset to VSR repair. Right atrial
pressures appear to be lower in survivors, whereas pulmo-
nary arterial systolic pressures were higher. To determine
the factors associated with mortality in patients undergoing
VSR repair, a number of logistic regression models were
attempted. As mentioned, we could not construct a multi-
Table 4. Management of Patients With CS and VSR or
Predominant LV Failure
VSR
(n 5 55)
LV
Failure
(n 5 884)
p
Value
Thrombolytic therapy 43.6% 34.5% 0.190
Intra-aortic balloon
counterpulsation
74.5% 52.6% 0.002
Angiography 67.3% 61.3% 0.396
Angioplasty 9.1% 32.9% , 0.001
Bypass surgery 40.0% 15.4% , 0.001
Mechanical ventilation 74.5% 75.3% 0.873
Data presented are percentages.
Table 5. Profile of Surgically Managed Patients With CS
and VSR
Survivors
(n 5 6)
Nonsurvivors
(n 5 25)
Age (yrs) 69 (6) 72 (25)
Female gender 50% (6) 60% (25)
Transferred from elsewhere 67% (6) 56% (25)
Prior myocardial infarction 17% (6) 8% (24)
Hypertension 33% (6) 58% (24)
Diabetes 0% (6) 21% (24)
Smoking 40% (5) 43% (21)
Anterior infarction 83% (6) 38% (24)
Inferior infarction 33% (6) 67% (24)
Apical infarction 50% (6) 13% (24)
Time from infarct onset to shock onset
(h)
52 (5) 16 (20)
Time from infarct onset to VSR (h) 154 (4) 13 (11)
Time from shock onset to surgical VSR
repair (h)
27 (5) 8 (17)
Heart rate (beats/min) 110 (6) 95 (21)
Systolic blood pressure (mm Hg) 94 (6) 85 (21)
Diastolic blood pressure (mm Hg) 55 (5) 51 (20)
Right atrial pressure (mm Hg) 13 (3) 17 (13)
Pulmonary arterial systolic pressure
(mm Hg)
62 (3) 40 (14)
Pulmonary capillary wedge pressure
(mm Hg)
23 (4) 21 (21)
Angiography 83% (6) 92% (25)
Bypass surgery 50% (6) 72% (25)
Data presented are medians or percentages (number of patients with data available).
Beats/min 5 beats per minute.
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variate model for surgical mortality, because of the small
number of survivors. As a result, a detailed profile of
survivors is presented in Table 6. The sole in-hospital
medical survivor was a 35-year-old male smoker with an
anterior MI. The time from MI onset to shock onset was
7.35 h, and angioplasty was performed. The highest CK
was 12,010 U/L; in-hospital ejection fraction was 43%;
and he was diagnosed with VSR 48 h after MI onset.
Comparison with acute severe MR. Ninety-eight patients
with CS secondary to acute severe MR were part of the
SHOCK Trial Registry (25). Selected variables from this
group are compared with our study group in Table 7.
Patients with VSR have less prior MI and were less likely to
be diabetic. Mean right atrial pressure was higher in the
VSR setting, but pulmonary capillary wedge pressure and
LV ejection fraction were similar. Patients with VSR had
poorer in-hospital survival compared with patients having
severe MR.
DISCUSSION
This SHOCK Trial Registry report describes a large series
of patients with acute MI complicated by VSR and CS. By
design, patients with VSR in the absence of shock are not
included in this registry. All patients were managed in
tertiary cardiac-care units. We observed a 87% mortality,
and this very poor outcome was seen across all participating
centers.
Demographic characteristics. Many of the observations in
our study confirm previous reports. Ventricular septal rup-
ture most often complicates a first MI, which may be
anterior, apical, or inferior in location. The infarct-related
vessel is usually severely stenosed with TIMI grade 0/1 flow.
Table 6. Profile of Surgical Survivors With CS and VSR
Survivor 1 Survivor 2 Survivor 3 Survivor 4 Survivor 5 Survivor 6
Age (yrs) 67 74 67 78 66 71
Gender male female male female female male
Transferred from elsewhere no yes yes no yes yes
Anterior infarction yes yes yes yes yes no
Inferior infarction no yes no no no yes
Time from MI onset to shock onset (h) 228 52 67 24 36 —
Time from MI onset to VSR (h) 236 — 89 219 36 —
Time from shock onset to VSR surgery (h) 11 27 139 200 — 5
Left-heart catheterization yes yes yes yes no yes
Angioplasty no no no no no no
Bypass surgery yes yes no no no yes
Systolic blood pressure (mm Hg)* 104 85 125 83 94 93
Diastolic blood pressure (mm Hg)* — 50 55 42 58 66
Heart rate (beats/min)* 118 105 115 72 150 100
Pulmonary capillary wedge pressure (mm Hg)* 23 20 24 — — 22
Pulmonary arterial systolic pressure (mm Hg)* 56 — 96 — — 62
Pulmonary arterial diastolic pressure (mm Hg)* 25 — — — — 22
Right atrial pressure (mm Hg)* 13 — 17 — — 11
*While on support measures. Data presented are medians or percentages.
Beats/min 5 beats per minute; MI 5 myocardial infarction.
Table 7. Patient Characteristics: VSR vs. Acute Severe MR in SHOCK Trial Registry Patients
Characteristic VSR* Severe MR* p Value
n 54 97
Mean age (yrs) 71.7 6 10.0 69.8 6 10.1 0.253
Female 57.4% 51.6% 0.502
History of hypertension 51.0% 59.0% 0.385
History of MI 15.1% 33.0% 0.020
Diabetes 17.0% 33.7% 0.035
Smoking 35.6% 46.0% 0.271
Anterior MI 49.0% 34.5% 0.106
Median MI to CS (hours) 15.8 13.2 0.601
Heart rate (beats/min) 101.6 6 22.3 (49) 97.1 6 24.1 (94) 0.246
Pulmonary capillary wedge pressure (mm Hg) 22.3 6 8.5 (42) 22.1 6 7.5 (76) 0.839
Right atrial pressure (mm Hg) 18.0 6 7.2 (25) 14.1 6 12.5 (42) 0.002
LV ejection fraction (%)† 40.6 6 11.0 (17) 38.7 6 17.2 (58) 0.281
In-hospital survival 13.0% 45.4% , 0.001
*One patent who had both MR and VSR was excluded from this analysis; †Left ventricular ejection fraction obtained at anytime
during the shock hospitalization.
() 5 Subgroup n.
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The absence of collateral flow to the infarcted area creates a
milieu for extensive transmural myocardial necrosis, predis-
posing to rupture.
The majority of our patients with rupture were female.
This differs from the male predominance reported in many
surgical (14,15,17,19,20,26) and post-mortem series
(27,28). The mean age in our study (72 years) is greater than
that previously reported. It appears consistent with the
aging of the population in general and the increased risk of
rupture with advancing age. Age also may contribute to the
extent of angiographic CAD, which appears to be more
severe than previously reported. The presence of CS in all
our patients may also account for the severity of CAD, but
the VSR group had less extensive CAD than those whose
shock was due to predominant LV failure.
Timing of VSR. The median time from MI onset to VSR
in our 24 subjects for whom timing data were recorded is
shorter than the three to eight days reported in the literature
(28). The universal presence of CS may have contributed to
this discrepancy. Early reperfusion strategies appear to have
decreased the incidence of cardiac rupture, free-wall rup-
ture, and VSR (29,30). There is concern, however, that
thrombolytic therapy may accelerate rupture in certain
patients (31). This is not supported by our observation that
there was no difference in time to VSR between patients
who did and did not receive thrombolytic therapy.
A bias toward later VSR in some surgical series also may
explain the discrepancy in VSR timing, and early death from
VSR before surgical repair may have led to under-reporting
in some series. Statistical representation may play a role
because the timing of post-infarction VSR does not appear
to be normally distributed; rather, it occurs either early or
relatively late after MI. Thus the mean time to VSR may
misrepresent the timing of rupture. In this situation, a few
cases of VSR that occur remotely from the MI may
markedly skew the overall reported time of VSR.
Prior surgical experience. Surgical intervention plays a
pivotal role in the management of unstable patients with
VSR after MI. Although a delay in intervention appears to
be associated with improved surgical results, a high early
mortality makes this approach untenable. Previous case
series, with exceptions, have been single-center, retrospec-
tive, longitudinal analyses. Many have reported surgical
survival alone, and patients with CS are often under-
represented. Gaudiani et al. (14) reported a 90% mortality
for patients requiring operation within 24 h of VSR. In the
series of Loisance et al. (16), 19 of 57 patients died before
surgery was attempted, and the 14 patients who made it to
surgery with CS had a 71% operative mortality. Similarly,
Radford et al. (17) reported a 73% (8/11) surgical mortality
at Massachusetts General Hospital, and reports from the
Mayo Clinic (20) have been similarly disappointing. By
contrast, Komeda et al. (13) reported a mortality of only
20% in 15 patients with VSR and CS, and Skillington et al.
(32) reported a 39% mortality in 41 such patients. A more
recent update reported a 52% mortality in 22 subjects with
VSR, MI and CS (33).
Surgical outcomes in the present study. Advances in
surgical technique and myocardial preservation have im-
proved outcomes for most patients with VSR complicating
acute MI (34). In addition, predictors of survival have been
identified (35,36). Yet, as illustrated by our data, the
subgroup with CS does poorly: only 7 of our 55 subjects
with VSR and CS survived. Because of the small number of
survivors, we were unable to develop a model for survival,
but our observations confirm some previous findings. Even
in this population with CS, patients with anterior MI and
apical VSR do better than those with inferior MI (21),
probably because the latter are usually anatomically com-
plex, surgically more challenging and have greater RV
infarction and dysfunction. In addition, we saw no addi-
tional benefit of concomitant bypass surgery in this small
sample: of our six survivors, two had VSR repair alone.
The times from MI onset to shock onset, from MI onset
to VSR, and from MI onset to surgical VSR appear to be
longer for survivors than for nonsurvivors. These observa-
tions are based on a very small number of survivors but are
consistent with previous reports in the literature. The
association of survival and later surgery may be explained by
survivorship bias. These data are not adequate to produce
clear conclusions about the timing of surgery for VSR,
considering the small number of survivors and of selection
bias. However, our disappointing results should not be
viewed as an excuse to postpone treatment of patients with
VSR. Our population included only patients who had
developed shock. Patients who had early VSR repair before
the onset of shock were excluded from our study. Our poor
outcomes once shock has developed would tend to support
the Class I indication for urgent early surgery before shock
onset when VSR complicates MI (37). Delaying surgery to
permit infarct healing risks the development of shock,
which is unpredictable and associated with poor surgical
prognosis. Despite the poor outcome, surgery in this setting
remains the best therapeutic option. Surgery may be near
futile for elderly patients with inferior MI complicated by
shock, VSR and other comorbidity.
Conclusions. This report from an international, prospec-
tive registry of patients with clinical CS highlights the
dismal outcome of those with VSR complicating acute MI.
Patients with VSR were more often elderly and female and
less often had multi-vessel CAD, compared with patients
whose shock was due to predominant LV failure. In most
patients, VSR occurred early after a first, index MI. Medical
management resulted in almost 100% mortality, and surgi-
cal outcome was poor once CS developed.
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